Guardant Health Inc
NASDAQ:GH

Watchlist Manager
Guardant Health Inc Logo
Guardant Health Inc
NASDAQ:GH
Watchlist
Price: 104.785 USD 1.53%
Market Cap: 13.5B USD

Wall Street
Price Targets

GH Price Targets Summary
Guardant Health Inc

Wall Street analysts forecast GH stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GH is 100.723 USD with a low forecast of 48.692 USD and a high forecast of 136.5 USD.

Lowest
Price Target
48.692 USD
54% Downside
Average
Price Target
100.723 USD
4% Downside
Highest
Price Target
136.5 USD
30% Upside
Guardant Health Inc Competitors:
Price Targets
4694
BML Inc
11% Upside
1846
Euroeyes International Eye Clinic Ltd
91% Upside
FLGT
Fulgent Genetics Inc
25% Upside
4544
H.U. Group Holdings Inc
12% Upside
INNV
InnovAge Holding Corp
21% Upside
RDNT
RadNet Inc
23% Upside
CSTL
Castle Biosciences Inc
1% Upside

Revenue
Forecast

Revenue Estimate
Guardant Health Inc

For the last 7 years the compound annual growth rate for Guardant Health Inc's revenue is 47%. The projected CAGR for the next 3 years is 30%.

47%
Past Growth
30%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Guardant Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Guardant Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GH's stock price target?
Price Target
100.723 USD

According to Wall Street analysts, the average 1-year price target for GH is 100.723 USD with a low forecast of 48.692 USD and a high forecast of 136.5 USD.

What is Guardant Health Inc's Revenue forecast?
Projected CAGR
30%

For the last 7 years the compound annual growth rate for Guardant Health Inc's revenue is 47%. The projected CAGR for the next 3 years is 30%.

Back to Top